405 related articles for article (PubMed ID: 1483669)
1. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
2. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
[TBL] [Abstract][Full Text] [Related]
3. Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension.
Omar MM; Fakhry SM; Mostafa I
J Egypt Soc Parasitol; 1998 Apr; 28(1):159-68. PubMed ID: 9617052
[TBL] [Abstract][Full Text] [Related]
4. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic sclerotherapy in a rat model of esophageal varices.
Nishida R; Inoue R; Takimoto Y; Hamashima H; Kita T
Scand J Gastroenterol; 1995 May; 30(5):489-96. PubMed ID: 7638578
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ethanolamine and polidocanol in the eradication of esophageal varices. A prospective randomized trial.
Balanzó J; Sainz S; Espinós JC; Such J; Segura J; Guarner C; Cussó X; Vilardell F
Endoscopy; 1989 Nov; 21(6):251-3. PubMed ID: 2693076
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
[TBL] [Abstract][Full Text] [Related]
8. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
[TBL] [Abstract][Full Text] [Related]
10. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol.
Nishida R; Inoue R; Takimoto Y; Kita T
J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514
[TBL] [Abstract][Full Text] [Related]
11. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.
Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H
Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349
[TBL] [Abstract][Full Text] [Related]
12. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial.
Iso Y; Kawanaka H; Tomikawa M; Matsumata T; Kitano S; Sugimachi K
Hepatogastroenterology; 1997; 44(14):467-71. PubMed ID: 9164520
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
[TBL] [Abstract][Full Text] [Related]
14. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
Neeman A; Leiser A; Kadish U
Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study.
Umehara M; Onda M; Tajiri T; Toba M; Yoshida H; Yamashita K
Gastrointest Endosc; 1999 Jul; 50(1):7-12. PubMed ID: 10385714
[TBL] [Abstract][Full Text] [Related]
16. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
Tsutsumi M; Takada A
Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
[No Abstract] [Full Text] [Related]
17. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate.
Kitano S; Koyanagi N; Iso Y; Higashi H; Sugimachi K
Hepatology; 1987; 7(5):810-5. PubMed ID: 3498673
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic injection sclerotherapy for esophagogastric variceal bleeding in children with biliary atresia.
Horigome H; Nomura T; Saso K; Hashimoto T; Suzuki T; Joh T; Ohara H; Akita S; Sobue S; Mizuno Y; Kato Y; Ohmi H; Itoh M
Hepatogastroenterology; 1999; 46(30):3060-2. PubMed ID: 10626160
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial of schedules for sclerosing esophageal varices. 1-versus 2-week intervals.
Higashi H; Kitano S; Hashizume M; Yamaga H; Sugimachi K
Hepatogastroenterology; 1989 Oct; 36(5):337-40. PubMed ID: 2695448
[TBL] [Abstract][Full Text] [Related]
20. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
